71. Hitchcock, M. J. M., “Review: Antiviral Portrait Series, Number 1; 2',3'-didehydro-2',3'- dideoxythymidine (D4T), and Anti-HIV Agent,” Antiviral Chemistry in Chemotherapy, 2 (1991), pp. 125-132.

- Smothers, K., “Pharmacology and Toxicology of AIDS Therapies,” The AIDS Reader, I (1991), pp. 29-35.

- McLeod, G. X. and S. M. Hammer, “Zidovudine: Five Years Later,” Annals of Internal Medicine, 117 (1992), pp. 487-501.

- Freiman, J. P., et al., “Hepatomegaly with Severe Steatosis in HIV-seropositive Patients,” AIDS, 7 (1993), pp. 379-385.

- Bacellar, H., et al., “Temporal Trends in the Incidence of HIV-I-related Neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992,” Neurology, 44 (1994), pp. 1892-1900.

- Parker, W. B. and Y. C. Cheng, “Mitochondrial Toxicity of Antiviral Nucleoside Analogs,” Journal of National Institutes of Health Research, 6 (1994), pp. 57-61.

- Chiu, D. and P. H. Duesberg, “The Toxicity of Azidothymidine (AZT) on Human and Animal Cells in Culture at Concentrations Used for Antiviral Therapy,” Genetica, 95 (1995), pp. 103-109.